Expression of Concern: Chaiprasongsuk et al. Hydroxylumisterols, Photoproducts of Pre-Vitamin D3, Protect Human Keratinocytes Against UVB-Induced Damage. Int. J. Mol. Sci. 2020, 21, 9374
International Journal of Molecular Sciences · 09.04.2026 · 27 (8) · 3359
DOI: 10.3390/ijms27083359 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2026. Verfasst von Ijms Editorial Office. Beteiligte Einrichtung: MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland. Hauptthemen laut MEDLINE: Keratinocytes, Ultraviolet Rays, Cholecalciferol. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With this notice, the International Journal of Molecular Sciences Editorial Office alerts the readers of concerns related to this article [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland.
Zitieren
APA
Ijms Editorial Office (2026). Expression of Concern: Chaiprasongsuk et al. Hydroxylumisterols, Photoproducts of Pre-Vitamin D3, Protect Human Keratinocytes Against UVB-Induced Damage. Int. J. Mol. Sci. 2020, 21, 9374. International Journal of Molecular Sciences, 27(8), 3359. https://doi.org/10.3390/ijms27083359
Vancouver
Ijms Editorial Office. Expression of Concern: Chaiprasongsuk et al. Hydroxylumisterols, Photoproducts of Pre-Vitamin D3, Protect Human Keratinocytes Against UVB-Induced Damage. Int. J. Mol. Sci. 2020, 21, 9374. International Journal of Molecular Sciences. 2026;27(8):3359. doi:10.3390/ijms27083359
BibTeX
@article{IjmsEditorialOffice2026,
author = {Ijms Editorial Office},
title = {Expression of Concern: Chaiprasongsuk et al. Hydroxylumisterols, Photoproducts of Pre-Vitamin D3, Protect Human Keratinocytes Against UVB-Induced Damage. Int. J. Mol. Sci. 2020, 21, 9374},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {8},
pages = {3359},
doi = {10.3390/ijms27083359}
}
EUVIMED